← FDA DRUG APPROVALS

FDA NDA · NDA020430

ORGARAN

Sponsor: ASPEN GLOBAL INC

APPLICATION
NDA020430
TYPE
NDA
ORIGINAL APPROVAL
1996-12-24
LATEST ACTION
2001-06-26
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

ORGARANDiscontinued
DANAPAROID SODIUM 750 UNITS/0.6ML · INJECTABLE · INJECTION

Approval history

2001-06-26Efficacy · Supplement 3 · standardReviewAP
1998-01-30Labeling · Supplement 2 · standardAP
1997-07-16Manufacturing (CMC) · Supplement 1 · standardAP
1996-12-24Type 1 - New Molecular Entity · Original · standardReviewAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →